Clinical Trial Detail

NCT ID NCT02401815
Title PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon
Indications

gastrointestinal stromal tumor

Advanced Solid Tumor

Therapies

PLX9486 + Sunitinib

Pexidartinib + PLX9486

PLX9486

Age Groups: adult senior

Additional content available in CKB BOOST